- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05404594
Multimodal Approach to the Ontogenesis of Nociception in Very Preterm and Term Infants (NOCI-Prem)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67000
- Recruiting
- Service de Pédiatrie - Hôpital d'Hautepierre
-
Contact:
- Pierre KUHN, Professor
- Phone Number: 03 88 12 77 79
- Email: pierre.kuhn@chru-strasbourg.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Experimental group: VPIs of gestational age less than or equal to 33 weeks on the day of birth and hospitalized in the neonatal intermediate care unit or the neonatal intensive care unit of the Neonatal department of the Hautepierre Hospital (Strasbourg University Hospital)
- Control group: Healthy full-term babies (> 37 weeks gestational age) hospitalized in the maternity ward of Strasbourg University Hospital
- Consent obtained from both parents
- Subject affiliated to a social health insurance plan.
Exclusion Criteria:
- - Any malformation known before inclusion
- Cerebral lesions discovered on cerebral ultrasound performed as part of the standard management of newborns (Intra-Ventricular Hemorrhages of grade III or IV of the Papile classification, Periventricular Leucomalacia)
- Unstable clinical status according to the investigator's judgment
- Expected transfer of the child to another hospital before the term of 40 weeks PMAs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Very preterm infant
Preterm infant below 33 weeks of GA
|
Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture. |
|
Active Comparator: Full term neonate
Term neonate from a gestational age of 37 weeks.
|
Two consecutive venipuncture (order randomly balanced) within a short period of time will be realized with and without the presence of the mother talking/singing to her VPI infant. In this intervention group, the mother will be supported to talk or to sing to her infants during before and during the venipuncture. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The cortical hemodynamic response profile
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes.
The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification.
The data set will be collected over a basal period, a stimulation period and a post-stimulation period.
Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates.
A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes.
The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification.
The data set will be collected over a basal period, a stimulation period and a post-stimulation period.
Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates.
A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes.
The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification.
The data set will be collected over a basal period, a stimulation period and a post-stimulation period.
Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates.
A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
The cortical hemodynamic response profile
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
The measurements will be performed using receiver and transmitter optodes to measure the variations of oxy and deoxyhemoglobin in the cerebral cortex below the optodes.
The optodes will be placed in the primary and secondary somatosensory areas, and in other cortical areas (nociceptive pathway and control areas) using the EEG 10-20 classification.
The data set will be collected over a basal period, a stimulation period and a post-stimulation period.
Response patterns will be analyzed by mixed models and compared in VPIs in the different APM groups and with term neonates.
A typical response associates an increase in oxyhemoglobin (Hb02) with a concomitant stability or decrease in deoxyhemoglobin (HHb).
|
During a venipuncture at 2 to 3 days of life in term neonates
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Comparison of the hemodynamic response profiles and salivary oxytocin levels during 2 consecutive venipunctures, without and with the addition of the maternal voice as a supplementary non-pharmacological pain strategies
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Analysis of the impact on the responses of maternal separation
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Analysis of the impact on the responses of maternal separation determined by the absence of early skin-to-skin contact (in the VPI < 3 days of life and in the term newborn < 2 hours of life).
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Comparison of the response profiles obtained in females and males
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Comparison of the response profiles obtained in females and males
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Comparison of the response profiles obtained in females and males
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Comparison of the response profiles according to the sex
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Comparison of the response profiles obtained in females and males
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Comparison of conduction velocities of small caliber nociceptive fibers
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Comparison of conduction velocities of small caliber nociceptive fibers measured by evoked potentials, in response to non-painful cold stimulation in the VPIs of different APMs groups.
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Correlational analyses by APM group
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Correlational analyses by APM group
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Correlational analyses by APM group
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Correlational analyses by APM group
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Correlational analyses, by APM group, between the different pain indicators in response to stimulation
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Facial pain behavior
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Facial pain behavior with the Neonatal Facial Coding System
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Facial pain behavior
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Facial pain behavior with the Neonatal Facial Coding System
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Facial pain behavior
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Facial pain behavior with the Neonatal Facial Coding System
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Facial pain behavior
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Facial pain behavior with the Neonatal Facial Coding System
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Pain index
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Pain index assessing the sympathetic and parasympathetic system
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Pain index
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Pain index assessing the sympathetic and parasympathetic system
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Pain index
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Pain index assessing the sympathetic and parasympathetic system
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Pain index
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Pain index assessing the sympathetic and parasympathetic system
|
During a venipuncture at 2 to 3 days of life in term neonates
|
|
Cortical evoked potentials
Time Frame: During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
Cortical evoked potentials in Cz according to EEG 10:20 classification
|
During a venipuncture (needed for the standard care of the infants) and realized around 30 (+/- 2) weeks PMAs in VPI
|
|
Cortical evoked potentials
Time Frame: During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
Cortical evoked potentials in Cz according to EEG 10:20 classification
|
During a venipuncture at 34 (+/-2) weeks PMAs in VPI
|
|
Cortical evoked potentials
Time Frame: During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
Cortical evoked potentials in Cz according to EEG 10:20 classification
|
During a venipuncture at 40 (+/-2) weeks PMAs in VPI
|
|
Cortical evoked potentials
Time Frame: During a venipuncture at 2 to 3 days of life in term neonates
|
Cortical evoked potentials in Cz according to EEG 10:20 classification
|
During a venipuncture at 2 to 3 days of life in term neonates
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7256
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Procedural Pain
-
Defense and Veterans Center for Integrative Pain...DepomedCompletedMinor Procedural PainUnited States
-
IRCCS Burlo GarofoloCompletedProcedural Pain ReliefItaly
-
IWK Health CentreCompletedNeonatal Procedural Pain ResponseCanada
-
Istanbul UniversityNot yet recruitingProcedural Pain | Procedural Anxiety | Breast Imaging
-
Hamad Medical CorporationRecruitingProcedural Pain | Procedural AnxietyQatar
-
Agri Ibrahim Cecen UniversityCompletedProcedural Pain | Procedure-Related Anxiety | Pediatric Wounds | Procedural FearTurkey (Türkiye)
-
University of UtahCompleted
-
Hakkari UniversitesiNot yet recruitingPain | Anxiety | Fear | Procedural Pain | Procedural Anxiety
-
Aynur Aytekin OzdemirCompletedProcedural Pain Relief | Fear PainTurkey
-
Hayatabad Medical ComplexNot yet recruiting
Clinical Trials on Maternal vocal contact
-
Elisa Della Casa MuttiniRecruitingPrematurity | Early InterventionItaly
-
Istituto per la Ricerca e l'Innovazione BiomedicaScienze Psicologiche,Pedagogiche,Università degli Studi di Palermo; UOC Neonatologia...RecruitingPostpartum Depression | Preterm BirthItaly
-
IWK Health CentreNova Scotia Health Research FoundationUnknownPain, Acute | Electroencephalography | Infant, NewbornCanada
-
Ataturk UniversityNot yet recruitingCesarean Section | Breastfeeding | Postpartum Period | Maternal StressTurkey (Türkiye)
-
National Institute on Deafness and Other Communication...Terminated
-
Vrushali AngadiCompleted
-
Far Eastern Memorial HospitalCompletedAged | Dysphonia | Speech Therapy
-
Azienda Ospedaliero Universitaria Maggiore della...UnknownIntubation Complication | Vocal Cord Dysfunction | Intubation;Difficult | Vocal Tone DisorderItaly
-
University Hospital, MontpellierActive, not recruitingDysodia | Vocal DisordersFrance
-
Medical University of ViennaUnknown